Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
Journal of Cardiovascular Ultrasound
;
: 140-144, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-54460
ABSTRACT
The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Sulfonamidas
/
Receptores de Endotelina
/
Defectos del Tabique Interatrial
/
Hipertensión Pulmonar
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Journal of Cardiovascular Ultrasound
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS